(Q46821332)

English

Interaction between polymorphisms in serotonin transporter (SLC6A4) and serotonin receptor 2A (HTR2A) genes predict treatment response to venlafaxine XR in generalized anxiety disorder

scientific article published on 21 August 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/22907732

Interaction between polymorphisms in serotonin transporter (SLC6A4) and serotonin receptor 2A (HTR2A) genes predict treatment response to venlafaxine XR in generalized anxiety disorder (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/22907732

0 references

Sneha Narasimhan

object named as

S Narasimhan

2

0 references

author name string

F W Lohoff

1

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/22907732

K Rickels

3

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/22907732

publication date

21 August 2012

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/22907732

The Pharmacogenomics Journal

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/22907732

13

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/22907732

5

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/22907732

464-469

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/22907732

https://scigraph.springernature.com/pub.10.1038/tpj.2012.33

0 references

Escitalopram in the treatment of generalized anxiety disorder

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.33

21 January 2018

Efficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder: A 6-month randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.33

21 January 2018

Antidepressants for the treatment of generalized anxiety disorder. A placebo-controlled comparison of imipramine, trazodone, and diazepam

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.33

21 January 2018

Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.33

21 January 2018

Pharmacogenetics of anxiolytic drugs.

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.33

21 January 2018

Pharmacogenetics of antidepressant drugs: current clinical practice and future directions

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.33

21 January 2018

Pharmacogenetics in the treatment of depression: pharmacodynamic studies

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.33

21 January 2018

Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.33

21 January 2018

Allelic Variation of Human Serotonin Transporter Gene Expression

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.33

21 January 2018

A relationship between serotonin transporter genotype and in vivo protein expression and alcohol neurotoxicity.

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.33

21 January 2018

Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.33

21 January 2018

Polymorphism of the serotonin transporter: implications for the use of selective serotonin reuptake inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.33

21 January 2018

Antidepressant response and the serotonin transporter gene-linked polymorphic region

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.33

21 January 2018

Sequence analysis of the serotonin transporter and associations with antidepressant response

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.33

21 January 2018

Antipanic efficacy of paroxetine and polymorphism within the promoter of the serotonin transporter gene

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.33

21 January 2018

Serotonin transporter gene promoter polymorphism predicts SSRI response in generalized social anxiety disorder

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.33

21 January 2018

Relation of serotonin transporter genetic variation to efficacy of escitalopram for generalized anxiety disorder in older adults

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.33

21 January 2018

Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.33

21 January 2018

Resequencing of serotonin-related genes and association of tagging SNPs to citalopram response

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.33

21 January 2018

HTR2A gene variation is involved in antidepressant treatment response

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.33

21 January 2018

Polymorphisms in GRIK4, HTR2A, and FKBP5 show interactive effects in predicting remission to antidepressant treatment

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.33

21 January 2018

Interaction of serotonin-related genes affects short-term antidepressant response in major depressive disorder

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.33

21 January 2018

Evidence for a combined genetic effect of the 5-HT(1A) receptor and serotonin transporter genes in the clinical outcome of major depressive patients treated with citalopram

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.33

21 January 2018

Polymorphisms in the 5-hydroxytryptamine 2A receptor and CytochromeP4502D6 genes synergistically predict fluvoxamine-induced side effects in japanese depressed patients

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.33

21 January 2018

Time to relapse after 6 and 12 months' treatment of generalized anxiety disorder with venlafaxine extended release

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.33

21 January 2018

Simultaneous genotyping of four functional loci of human SLC6A4, with a reappraisal of 5-HTTLPR and rs25531.

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.33

21 January 2018

Pharmacological treatment of generalized anxiety disorder

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.33

21 January 2018

Association between the serotonin transporter promoter polymorphism and personality traits in a primarily female population sample

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.33

21 January 2018

Association between serotonin transporter gene polymorphism and anxiety-related traits.

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.33

21 January 2018

Imaging genetics: perspectives from studies of genetically driven variation in serotonin function and corticolimbic affective processing

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.33

21 January 2018

HTR2A: association and expression studies in neuropsychiatric genetics

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.33

21 January 2018

Electroconvulsive shock decreases binding to 5-HT2 receptors in nonhuman primates: an in vivo positron emission tomography study with [18F]setoperone

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.33

21 January 2018

Neuroimaging studies of mood disorders

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.33

21 January 2018

The effect of citalopram hydrobromide on 5-HT2A receptors in the impulsive-aggressive dog, as measured with 123I-5-I-R91150 SPECT.

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.33

21 January 2018

Cortical 5-HT2A receptor signaling modulates anxiety-like behaviors in mice.

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2012.33

21 January 2018

Identifiers

10.1038/TPJ.2012.33

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/22907732

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/22907732

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46821332&oldid=2133679081"